Skip to content

Study on the clinical effect of Zhibai Fuxia decoction combined with rhGH on prediction of adult height in children with precocious puberty

Study on the clinical effect of Zhibai Fuxia decoction combined with rhGH on prediction of adult height in children with precocious puberty

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035769
Enrollment
Unknown
Registered
2020-08-16
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Precocious Puberty

Interventions

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Those who met the diagnostic criteria of peripheral precocious puberty, had abnormal sex hormone, B-ultrasound and X-ray examination, but the sex hormone provocation test did not meet the diagnosis of true precocious puberty; (2) In addition to the main symptoms, it was accompanied by five heart trouble, hot flushes, fear of heat, red cheekbones, night sweats, irritability and irritability, dry throat and dry mouth, short yellow urine, dry stool, or no moss and thin pulse. (3) The age of onset was less than 8 years in girls and 9 years in boys; (4) Girls have not menarche, and their bone age is less than 11 years old or (bone age age age) < 2 years old; boys have no ejaculation and their bone age is less than 13 years old; (5) Those who sign informed consent.

Exclusion criteria

Exclusion criteria: (1) True precocious puberty caused by intracranial organic lesions; (2) Pseudoprecocious puberty, including adrenal or ovarian tumors, fibrous dysplasia associated with precocious puberty syndrome, ingestion of Estrogen; (3) Precocious puberty of the opposite sex; (4) Tanner IV and with menses; (5) Previous history of mental illness or severe heart, brain or neurological disorder.

Design outcomes

Primary

MeasureTime frame
height;weight;Growth rate of height;Size of breast and areola;Size of mastoid nucleus;Growth of pubic and axillary hairs;Vaginal discharge;labia coloration;coating on the tongue;pulse;Bone age and predicted height;Volume measurement of uterus and ovary;Serum sex hormones;Serum ALT, BUN, Cr;TCM syndrome score;BMI;

Countries

China

Contacts

Public ContactJian Shen

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

shenj_78@126.com+86 13917422249

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026